In vitro elimination of EL4 cancer cells from spermatogonia stem cells by miRNA-143- and 206-loaded folic acid-conjugated PLGA nanoparticles

Nanomedicine (Lond). 2022 Apr;17(8):531-545. doi: 10.2217/nnm-2021-0210. Epub 2022 Mar 10.

Abstract

Aim: MiRNA's-143 and -206 are powerful apoptotic regulators in cancer cells. This study aimed to use miRNA-143- and 206-loaded poly(lactic-co-glycolic) acid (PLGA) nanoparticles conjugated with folic acid to induce apoptosis in the EL4 cancer cells. Materials & methods: The therapy was conducted in six groups: treatment with both miRNAs simultaneously (mixed miRNAs), miRNA-206 treatment, miRNA-143 treatment, blank PLGA, blank polyethylenimine (PEI) and complex PEI-miRNAs. Results: In terms of viability, in mixed miRNAs no synergistic effect was observed on EL4 cell elimination. However, in the single miRNA-206 group, a stronger apoptotic effect was observed than the mixed miRNAs group and single miRNA-143 group alone. Conclusion: MiRNAs' apoptotic induction effects in cancer cells were found to be remarkable.

Keywords: apoptosis; cancer; miRNA; nanoparticle; spermatogonia stem cell.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Folic Acid
  • Humans
  • Lactic Acid
  • Male
  • MicroRNAs* / genetics
  • Nanoparticles*
  • Neoplasms*
  • Polyethyleneimine
  • Polyglycolic Acid
  • Polylactic Acid-Polyglycolic Acid Copolymer
  • Spermatogonia
  • Stem Cells

Substances

  • MicroRNAs
  • Polylactic Acid-Polyglycolic Acid Copolymer
  • Polyglycolic Acid
  • Lactic Acid
  • Polyethyleneimine
  • Folic Acid